Register for Upcoming Webinar on DEC. 8 @ 11AM

2024 China NMPA Bluebook is here:

Seven Cardio Devices Proceed to Innovation Approval


NMPA granted ten special statuses in August 2021, among them are seven innovation cardio devices:

  • Boston Scientific Corporation: Vascular Plaque Atherectomy System
  • TriReme Medical: Paclitaxel Drug-Coated Peripheral Balloon Catheter
  • Shandong Weiji: Umimus Coated Coronary Artery Balloon Dilatation Catheter
  • Hanzhou Dejin: Transapical Mitral Valve Repair System
  • Shanghai Xinwei: Intracranial Artery Drug-coated Balloon Catheter
  • Jinshi Bio: Transcatheter Aortic Valve System
  • Shanghai Shenqi: Transcatheter Mitral Valve Clamp and Steerable Guiding Catheter
  • Guangzhou Ruiqina: Macular Compression Band
  • Beijing Pingchi: Deep Brain Stimulation System
  • Jiangsu Jingce: Non-invasive Blood Glucose System

How to Qualify the Innovation Approval?

Three fast-track channels have been established by NMPA to encourage innovation and deal with unmet medical needs: Innovation Approval, Priority Review, and Emergency Approval.

The “Innovation Approval Procedure for Medical Devices” lists four criteria for domestic or imported Class II / Class III medical devices manufacturers to apply:

  • Provide significant clinical application value,
  • Own valid invention patent and have China Patent & Trade Office coverage,
  • Complete the preliminary study on a prototype with traceable data, and
  • Have an authorized in-country legal entity.

If the “innovation status” is granted (which does not mean “approval”), the device will be allocated ‘front-of-queue’ priority throughout the registration process. The granted priority affects the classification determination, pre-clinical testing, QMS auditing, and NMPA reviewing/approving processes. Meanwhile, a specially assigned NMPA officer would check in and provide guidance throughout the whole expedited process.

The fast-track channels will greatly accelerate the registration process and CMD and help you evaluate the possibilities of your application. For our comprehensive review of the fast-track channels, please click HERE.

If you have any further questions about anything related to this topic, please contact us at

Have Questions?

Related Services


Recent Events

Related Posts


Get Updated

Receive Updates in Your Inbox